Wary pharma: AstraZeneca sours on UK

For all the Trumpian chaos in Latin America, no other developing-world regional economy has done so well in the past year. We examine the Donroe dividend. The cost to make jollof rice, a staple dish in Nigeria and Ghana, is a window into the countries’ economies. And the BBC wave ...  Show more

Ukraine is intensifying cross-border attacks in a strategic and psychological effort to make ordinary Russians take notice of the war. We have been collecting reports from the ground on shifting attitudes as occupied Crimea comes under fire. Why the valuation of Elon Musk’s Space ...  Show more

Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous air wings are the future of war in the sky. And how scientists in the Caribbean a ...  Show more

Trade ties between <a href="https://www.economist.com/the-americas/2024/11/17/brazil-courts-china-as-its-musk-feud-erupts-again?utm_campaign=a.io&utm_medium=audio.podcast.np&utm_source=theintelligence&utm_content=discovery.content.anonymous.tr_shownotes_na-na_article&utm_term= ...

America’s health secretary, RFK Jr, is known for his opposition to vaccines, particularly mRNA jabs, that have the potential to treat a large swathe of diseases. Slashing funding will have long term implications beyond America. Our correspondent visits Britain’s biggest and newes ...  Show more

With China as its new rival, America is reviving old wartime facilities across the Pacific. Our correspondent visits an abandoned airfield that has been given new life. The outlook for climate technology is surprisingly bright. And why the universe of Hello Kitty keeps expanding. ...  Show more